Analysis of organ metabolism with cancer growth can unravel systemic changes that occur with cancer and with cancer-induced cachexia. Cancer-induced cachexia, commonly observed with pancreatic cancer, causes tissue wasting, intolerance to chemotherapy, and poor quality of life. Here, we identified alterations of metabolic pathways in the spleen, liver, pancreas, lung, heart, brain and kidney following growth of cachexia-inducing and non-cachexia inducing pancreatic cancer xenografts. These results highlight the systemic metabolic changes that occur with cancer and with cancer induced cachexia that may lead to the development of organ-based early biomarkers as well to organ-based metabolic treatment strategies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords